2011
DOI: 10.1503/cmaj.101371
|View full text |Cite
|
Sign up to set email alerts
|

An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

6
47
0
4

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(57 citation statements)
references
References 14 publications
6
47
0
4
Order By: Relevance
“…15,16 Using a Poisson regression analysis and a case-crossover methodology, we analyzed mumps data reported to the Taiwan CDC from 2006 to 2011. We found that the incidence of mumps was highest during the summer months but that incidence was positively correlated with increased mean temperature and vapor pressure in both the long-term and acute effect analyses.…”
Section: Discussionmentioning
confidence: 99%
“…15,16 Using a Poisson regression analysis and a case-crossover methodology, we analyzed mumps data reported to the Taiwan CDC from 2006 to 2011. We found that the incidence of mumps was highest during the summer months but that incidence was positively correlated with increased mean temperature and vapor pressure in both the long-term and acute effect analyses.…”
Section: Discussionmentioning
confidence: 99%
“…28 However, given a VE of 90% and a basic reproductive number of 4, 6, or 8, respectively, Deeks and colleagues estimated that coverage needs to exceed 83.3%, 92.6%, or 97.2% to provide herd immunity and prevent mumps outbreaks. 29 In contrast, in the adult cohort the number of received doses varied according to age, and only about a third had received 2 vaccinations. Coverage in the now adult age groups had historically been low in Germany and only increased in the recent decade: a cross-sectional study in 1988 examining ~86 100 VCs of 10-to 12-y-old children in Bavaria yielded a mumps vaccination coverage of only 55%.…”
Section: Discussionmentioning
confidence: 95%
“…Since previous surveys suggest that a substantial proportion of young adults living in the Western federal states of Germany has <2 mumps vaccinations, thereby forming a relevant pool of susceptibles for further outbreaks, it seems plausible that from a public health point of view priority should be given to close these vaccination gaps. Given the current mumps vaccine, two-dose coverage rates should exceed 95% 29 in all age groups born after vaccine introduction into the routine schedule to prevent future outbreaks. Therefore, in Germany interventions are needed that are specifically targeted at adolescents and young adults who have received <2 vaccine doses during their childhood or have an unknown vaccination status.…”
Section: Discussionmentioning
confidence: 99%
“…20 For a single dose the effectiveness is 78% (median, range: 49-92%) and for 2 doses it is 88% (median, range: 66-95%). 21,22 All the cases were village residents except for 3 case-patients who worked in the village. There was no secondary transmission to individuals who lived outside the village indicating that population immunity provided by high two-dose coverage levels of MMR vaccine may have been more effective in limiting transmission in a less crowded setting.…”
Section: Discussionmentioning
confidence: 99%